首页> 外文期刊>International Journal of Pharmaceutics >Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
【24h】

Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.

机译:由两亲性全氟烷基α-环糊精衍生物制成的新型纳米颗粒:无环鸟苷的制备,表征和应用。

获取原文
获取原文并翻译 | 示例
           

摘要

The preparation of aqueous suspensions of nanoparticles of the fluorinated amphiphilic alpha-cyclodextrins hexakis[6-deoxy-6-(3-perfluoroalkylpropanethio)-2,3-di-O-methyl]-alpha-cyclodextr in and their hydrocarbon analogues was studied. The complexation of acyclovir by modified alpha-cyclodextrin, the encapsulation efficiency and release profile were measured as an assessment of the properties of such nanoparticles regarding drug delivery applications. Stable aqueous suspensions of nanoparticles were prepared using nanoprecipitation method without using surface-active agent. The organic solvent (ethanol) and cyclodextrin concentration (0.4 mM) were carefully selected. The nanoparticles prepared from these new amphiphilic alpha-cyclodextrin derivatives according to optimized conditions have an average diameter of 100 nm for fluorinated derivatives and 150 nm for hydrocarbon analogues. Suspensions were stable over at least 9 months. Acyclovir forms inclusion complexes of 1:1 stoichiometry and high stability constants (from 700 mol L(-1) to 4000 mol L(-1) in ethanol) as assessed from UV/vis spectroscopy and Electrospray Ionization Mass Spectroscopy. Satisfactory loading of acyclovir inside the nanoparticles was achieved according to the "highly loaded" preparation method (encapsulation efficiency approximately 40%). Nanoparticles based on the fluorinated compounds delayed the drug release up to 3 h with little initial burst release. Fluorinated amphiphilic alpha-cyclodextrins self-assemble in the form of nanospheres that encapsulate acyclovir and allow sustained release, showing their potential for applications to drug delivery.
机译:研究了氟化两亲性α-环糊精六[6-脱氧-6-(3-全氟烷基丙硫基)-2,3-二-O-甲基]-α-环糊精纳米颗粒及其烃类似物的水悬浮液的制备。测量了经修饰的α-环糊精对无环鸟苷的络合,包封效率和释放曲线,作为对此类纳米颗粒有关药物递送应用的性质的评估。使用纳米沉淀法而不使用表面活性剂制备稳定的纳米颗粒水悬浮液。仔细选择有机溶剂(乙醇)和环糊精浓度(0.4 mM)。根据优化条件,由这些新的两亲性α-环糊精衍生物制备的纳米粒子的氟化衍生物平均直径为100 nm,烃类似物平均直径为150 nm。悬浮液在至少9个月内保持稳定。从紫外线/可见光谱和电喷雾电离质谱法评估,阿昔洛韦形成化学计量比为1:1和高稳定性常数(乙醇中从700 mol L(-1)到4000 mol L(-1)的包合物)。根据“高负载”制备方法(包封效率约40%),纳米颗粒内部无环鸟苷的负载令人满意。基于氟化化合物的纳米颗粒将药物释放延迟了3小时,几乎没有最初的爆发释放。氟化两亲性α-环糊精以纳米球的形式自组装,该纳米球封装了阿昔洛韦并允许持续释放,显示了其在药物递送中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号